↓ Skip to main content

Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer

Overview of attention for article published in European Journal of Cancer (1965), June 2024
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#30 of 7,027)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
25 news outlets
twitter
3 X users

Readers on

mendeley
3 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer
Published in
European Journal of Cancer (1965), June 2024
DOI 10.1016/j.ejca.2024.114145
Pubmed ID
Authors

Andrew Dj Pearson, Steven G DuBois, Margaret E Macy, Teresa de Rojas, Martha Donoghue, Susan Weiner, Holly Knoderer, Ronald Bernardi, Vickie Buenger, Guillaume Canaud, Lewis Cantley, John Chung, Elizabeth Fox, John Friend, Julia Glade-Bender, Igor Gorbatchevsky, Lia Gore, Abha Gupta, Douglas S Hawkins, Dejan Juric, Leigh Anna Lang, Danielle Leach, Danny Liaw, Giovanni Lesa, Franca Ligas, Gavin Lindberg, Wendy Lindberg, Donna Ludwinski, Lynley Marshall, Andrew Mazar, Joe McDonough, Karsten Nysom, Christopher Ours, Alberto Pappo, D William Parsons, Amy Rosenfeld, Nicole Scobie, Malcolm Smith, Danielle Taylor, Brenda Weigel, Amy Weinstein, Dominik Karres, Gilles Vassal

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 3 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 1 33%
Unknown 2 67%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 33%
Unknown 2 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 175. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 July 2024.
All research outputs
#245,342
of 26,450,025 outputs
Outputs from European Journal of Cancer (1965)
#30
of 7,027 outputs
Outputs of similar age
#3,229
of 313,938 outputs
Outputs of similar age from European Journal of Cancer (1965)
#1
of 61 outputs
Altmetric has tracked 26,450,025 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,027 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.3. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 313,938 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 61 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.